Author

Cendrine Lemoine

Sanofi (France)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alexandra Maria PoosiD· 1 shared Alexey RakiD· 1 shared Bachisio ZicchedduiD· 1 shared Benjamin T. DiamondiD· 1 shared Damian J. GreeniD· 1 shared Dragan JevremovićiD· 1 shared Esteban BraggioiD· 1 shared Francesco MauraiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra Maria PoosORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Benjamin T. Diamond, Linda Banovic Baughn, Mansour Poorebrahim, Alexandra Maria Poos, Holly Lee, Marcella Kaddoura, Julia Erin Wiedmeier, Michael A. Durante, Gregory E. Otteson, Dragan Jevremović, Hongwei Tang, Stefan Fröhling, Marc‐Andrea Baertsch, Marios Papadimitriou, Bachisio Ziccheddu, , Francesco Maura

This study identifies biallelic CD38 loss as a mechanism of resistance to anti-CD38 antibodies in multiple myeloma, with specific mutations affecting antibody efficacy.

Blood · Jun 10, 2025Peer-reviewedCancer Biology